268 related articles for article (PubMed ID: 11120901)
1. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
[TBL] [Abstract][Full Text] [Related]
2. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
[TBL] [Abstract][Full Text] [Related]
3. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma.
Spiropoulos K; Trakada G; Nikolaou E; Prodromakis E; Efremidis G; Pouli A; Koniavitou A
Respir Med; 2003 Aug; 97(8):983-9. PubMed ID: 12924528
[TBL] [Abstract][Full Text] [Related]
5. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine.
Barczyk A; Pierzchala W; Sozañska E
Respir Med; 2003 Jun; 97(6):726-33. PubMed ID: 12814161
[TBL] [Abstract][Full Text] [Related]
8. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
Patel IS; Seemungal TA; Wilks M; Lloyd-Owen SJ; Donaldson GC; Wedzicha JA
Thorax; 2002 Sep; 57(9):759-64. PubMed ID: 12200518
[TBL] [Abstract][Full Text] [Related]
9. Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease.
Chalmers GW; Macleod KJ; Sriram S; Thomson LJ; McSharry C; Stack BH; Thomson NC
Eur Respir J; 1999 Jun; 13(6):1288-92. PubMed ID: 10445603
[TBL] [Abstract][Full Text] [Related]
10. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
Gompertz S; Bayley DL; Hill SL; Stockley RA
Thorax; 2001 Jan; 56(1):36-41. PubMed ID: 11120902
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
12. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
13. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
14. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
15. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
16. Exhaled nitric oxide correlated with induced sputum findings in COPD.
Silkoff PE; Martin D; Pak J; Westcott JY; Martin RJ
Chest; 2001 Apr; 119(4):1049-55. PubMed ID: 11296168
[TBL] [Abstract][Full Text] [Related]
17. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
18. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
19. Safety of sputum induction during exacerbations of COPD.
Bathoorn E; Liesker J; Postma D; Koëter G; van Oosterhout AJ; Kerstjens HA
Chest; 2007 Feb; 131(2):432-8. PubMed ID: 17296644
[TBL] [Abstract][Full Text] [Related]
20. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]